Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.75 DKK | +1.61% |
|
+2.40% | +0.61% |
26/06 | Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application | MT |
25/06 | US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.23% | 76.24B | |
+13.87% | 8.76B | |
-0.98% | 8.17B | |
-36.08% | 6.63B | |
+2.75% | 4.13B | |
-7.61% | 3.8B | |
-11.12% | 3.32B | |
+7.70% | 3.2B | |
+5.70% | 3.19B |
- Stock Market
- Equities
- HLUN B Stock
- LUN Stock
- News Lundbeck
- Transcript : H. Lundbeck A/S Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 09